Clinical trial
Efficacy of Preoperative Tirzepatide, Ketogenic Diet, and Standard Care on 1-Year Weight Loss After One Anastomosis Gastric Bypass (OAGB)
NCT07622992 is registered in ClinicalTrials.gov with Mario Musella MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Preoperative Tirzepatide, Ketogenic Diet, and Standard Care on 1-Year Weight Loss After One Anastomosis Gastric Bypass (OAGB)
- Lead sponsor
- Mario Musella MD
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 1, 2027
- Completion date
- December 1, 2029
- Enrollment
- 96 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obesity (bmi > 35) and diabetes mellitus, obesity (bmi > 35) and dyslipemia, obesity (bmi > 35) and high blood pressure